Factors favoring co-evolution of pseudomonas aeruginosa and its viruses in microbial communities of infected wound surfaces and prospects for phage therapy

Pseudomonas Aeruginosa: Symptoms of Infection, Antibiotic Resistance and Treatment

Volumn , Issue , 2012, Pages 37-66

  Krylov, V N ^a   Shaburova, O V ^a  

^a MECHNIKOV RESEARCH INSTITUTE FOR VACCINES AND SERA   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892220140     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (101)

1. Chen, LF; Falagas, ME; Peleg, AY. Facing the rising tide of multidrug resistant Gram-negative pathogens. Healthcare Infection, 2011 V.16, P. 1-5.
2. Kadavy, DR; Hornby, JM; Haverkost, T. and Nickerson, KW. Natural Antibiotic Resistance Bacteria Isolated from Larvae of the Oil Fly, Helaeomyia petrolei. Applied and Environmental Microbiology, 2000 V. 66, No. 11, P. 4615-4619.
3. Chander, Y; Goyal, SM; Gupta, SC. Antimicrobial resistance of Providencia sp. isolated from animal manure. Vet. J., 2006 V. 172, P. 188-191.
4. Chapalain, A; Rossignol, G; Lesouhaitier, O; Merieau, A; Gruffaz, C; Guerillon, J; Meyer, JM; Orange, N; Feuilloley, MG. Comparative study of 7 fluorescent pseudomonad clinical isolates. Can J. Microbiol., 2008 V. 54, P. 19-27.
5. Madi, A; Lakhdari, O; Blottière, HM; Guyard-Nicodème, M; Le Roux, K; Groboillot, A; Svinareff, P; Doré, J; Orange, N; Feuilloley, MGJ; Connil, N. The clinical Pseudomonas fluorescens MFN1032 strain exerts a cytotoxic effect on epithelial intestinal cells and induces Interleukin-8 via the AP-1 signaling pathway. BMC Microbiology, 2010 V. 10, P. 215.
6. Lombardi, G; Luzzaro, F; Docquier, JD; Riccio, ML; Perilli, M; Coli, A; Amicosante, G; Rossolini, GM; Toniolo, A. Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-1 metallo-ß-lactamase. J. Clin. Microbiol., 2002 V. 40, P. 4051-4055.
7. Yomoda, S; Okubo, T; Takahashi, A; Murakami, M; Iyobe, S. Presence of Pseudomonas putida Strains Harboring Plasmids Bearing the Metallo-ß-Lactamase Gene bla IMP in a Hospital in Japan. J. Clin. Microbiol., 2003 V. 9, P. 4246-4251.
8. Akimkin, VG; Bondarenko, VM; Voroshilova, NN; Darbeeva, OS; Baiguzina, FA. Practical use of adapted Salmonella bacteriophage for the treatment and prevention of nosocomial infections. Zh Mikrobiol Epidemiol Immunobiol. 1998, V. 6, P. 85-86.
9. Aslanov, BI; Yafaev, RCh; Zueva, LP. The ways of rational use of pyocianea bacteriophages in medical and anti-epidemic practice. Zh. Mmikrobiol. 2003, V5, P. 72-76.
10. Gabriélian, NI; Gorskaia, EM; Spirina, TS; Darbeeva, OS; Maiskaia, LM. Sensitivity of nosocomial microflora circulating in a transplantation clinic to medicinal bacteriophages. Zh. Mikrobiol. Epidemiol. Immunobiol. 2004 V. 6, P. 6-10.
11. Gorski, A; Miedzybrodzki, R; Borysowski, J; Weber-Dabrowska, B; Lobocka, M; Fortuna, W; Letkiewicz, S; Zimecki, M; Filby, G. Bacteriophage therapy for the treatment of infections. Curr. Opin. Investig. Drugs. 2009 V. 10, P. 766-774.
12. Lazareva, EB; Smirnov, SV; Khvatov, VB; Spiridonova, TG; Bitkova, EE; Darbeeva, OS; Maiskaia, LM; Parfeniuk, RL; Men'shikov, DD. Efficacy of bacteriophages in compl treatment of patients with burn wounds. Antibiot. Khimioter. 2001 V. 1, P. 10-14.
13. Letkiewicz, S; Miedzybrodzki, R; Klak, M; Jonczyk, E; Weber-Dabrowska, B; Górski, A. The perspectives of the application of phage therapy in chronic bacterial prostatitis. FEMS Immunol. Med. Microbiol. 2010 V. 2, P. 99-112.
14. Lakhno, VM; Bordunovskii, VN. Use of bacteriophage therapy in surgical practice. Vestn. Khir. Im. I I Grek. 2001 V. 160(1), P. 122-125.
15. Perepanova, TS; Darbeeva, OS; Kotliarova, GA; Kondrat'eva, EM; Maiskaia, LM; Malysheva, VF; Baiguzina, FA; Grishkova, NV. (1995). The efficacy of bacteriophage preparations in treating inflammatory urologic diseases. Urol. Nefrol. (Mosk) V. 5, P. 14-17.
16. Slopek, S; Durlakowa, I; Weber-Dabrowska, B; Kucharewicz-Krukowska, A; Dabrowski, M; Bisikiewicz, R. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results. Arch. Immunol. Ther. Exp. (Warsz), 1983 V. 3, P. 267-291.
17. Slopek, S; Durlakowa, I; Weber-Dabrowska, B; Kucharewicz-Krukowska, A; Dabrowski, M; Bisikiewicz, R. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results. Arch. Immunol. Ther. Exp. (Warsz), 1983 V. 3, P. 293-327.
18. Slopek, S; Kucharewicz-Krukowska, A; Weber-Dabrowska, B; Dabrowski, M. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases. Arch. Immunol. Ther. Exp. (Warsz), 1985 V. 2, P. 219-240.
19. Slopek, S; Kucharewicz-Krukowska, A; Weber-Dabrowska, B; Dabrowski, M. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children. Arch. Immunol. Ther. Exp. (Warsz), 1985 V. 2, P. 241-259.
20. Slopek, S; Kucharewicz-Krukowska, A; Weber-Dabrowska, B; Dabrowski, M. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections. Arch. Immunol. Ther. Exp. (Warsz), 1985 V. 2, P. 261-273.
21. Slopek, S; Weber-Dabrowska, B; Dabrowski, M; Kucharewicz-Krukowska, A. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Ex. (Warsz), 1987 V. 5, P. 569-583.
22. Weber-Dabrowska, B; Dabrowski, M; Slopek, S. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. (Warsz), 1987 V. 5, P. 563-568.
23. Zimecki, M; Artym, J; Kocieba, M; Weber-Dabrowska, B; Borysowski, J; Gorski, A. Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus. BMC Microbiol., 2009 V. 9, P. 169.
24. " INTRALYTIX" , (http://www.intralytix.com)
25. " Phage Therapy Center" , (http://www.phagetherapycenter.com)
26. Verbeken, G; De Vos, D; Vaneechoutte, M; Merabishvili, M; Zizi, M; Pirnay, JP. European regulatory conundrum of phage therapy. Future Microbiol., 2007 V. 2(5), P. 485-491.
27. Miedzybrodzki, R; Fortuna, W; Weber-Dabrowska, B; Górski, A. Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. Postepy Hig Med Dosw (Online), 2007 V. 3 (61) P. 461-465.
28. Krylov, VN. Use of live phages for therapy on a background of co-evolution of bacteria and phages. 2011. http://interesjournals.org/IRJM/Pdf/2011/October/Krylov.pdf
29. Faruque, SM; Mekalanos, JJ. Pathogenicity islands and phages in Vibrio cholerae evolution. Trends in Microbiology, 2003 V. 11, P. 505-510.
30. Miao, E; Miller, SI. Bacteriophages in the evolution of pathogen-host interactions. PNAS, 1999 V. 17 P. 9452-9454.
31. Tinsley, CR; Bille, E; Nassi, X. Bacteriophages and pathogenicity: more than just providing a toxin? Microbes and Infection, 2006 V. 5, P. 1365-1371.
32. Kaplan, AM; Akhverdian, VZ; Reulets, MA; Krylov, VN. Compatibility of transposable phages of Escherichia coli and Pseudomonas aeruginosa. I. Co-development of phages Mu and D3112 and integration of phage D3112 into RP4:Mu plasmid in Pseudomonas aeruginosa cells. Genetika, 1988 V. 4, P. 634-640.
33. Gorbunova, SA; Ianenko, AS; Akhverdian, VZ; Reulets, MA; Krylov, VN. Expression of Pseudomonas aeruginosa transposable phages in Pseudomonas putida cells. I. The establishment of a lysogenic state and the effectiveness of lytic development. Genetika, 1985 V. 9, P. 1455-1463.
34. Krylov, V; Merlin, C; Toussaint, A. Introduction of Pseudomonas aeruginosa mutator phage D3112 into Alcaligenes eutrophus strain CH34. Res. Microbiol., 1995 V. 146(3), P. 245-250.
35. Krylov, VN; Plotnikova, TG; Kulakov, LA; Fedorova, TV; Eremenko, EN. Integration of the genome of the Mu-like Pseudomonas aeruginosa bacteriophage D3112 into plasmid RP4 and its hybrid plasmid transfer into Pseudomonas putida and Escherichia coli C600 bacteria. Genetika. 1982 V. 18(1), P. 5-12.
36. Plotnikova, TG; Ianenko, AS; Kirsanov, NB; Krylov, VN. Transposition of the phage D3112 genome in Escherichia coli cells. Genetika, 1983 V. 10, P. 1611-1615.
37. Masignani, V; Giuliani, MM; Tettelin, H; Comanducci, M; Rappuoli, R; Scarlato, V. Mu-like Prophage in serogroup B Neisseria meningitidis coding for surface-exposed antigens. Infect. Immun., 2001 V. 4, P. 2580-2588.
38. Kuo, TT; Chiang, CC; Chen, SY; Lin, JH; Kuo, JL. A long lytic cycle in filamentous phage Cf1tv infecting Xanthomonas campestris pv. citri. Arch. Virol., 1994 V. 135, P. 253-264.
39. Rakonjac, J; Bennett, NJ; Spagnuolo, J; Gagic, D; Russel, M. Filamentous Bacteriophage: Biology, Phage Display and Nanotechnology Applications. Curr. Issues Mol. Biol., 2011, V2, P. 51-76. Online journal at http://www.cimb.org.
40. Johansen, HK; Gøtzsche, PC. Cochrane Database Syst Rev. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis. 2008, Oct 8;(4):CD001399.
41. Miller, RV; Whyte, LG. (Eds). Polar Microbiology: Life in a Deep Freeze. ASM Press, Washington DC. 2012.
42. Davis, MH; P; Dunkley, RM; Harden, K; Harding, JM; Laidlaw, A M; Morris, and R. A. B. Wood. Cause: types of wound and ulcers, In The wound programme. Centre for Medical Education, Dundee: United Kingdom; 1992; P. 109-132.
43. Bowler, PG; Duerden, BI; Armstrong, DG. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev, 2001 V. 14(2), P. 244-269.
44. Dzhusupova, AB; Plotnikova, TG; Krylov, VN. Detection of transduction by virulent bacteriophage phiKZ of Pseudomonas aeruginosa chromosomal markers in the presence of plasmid RMS148. Genetika, 1982 V. 18(11), P. 1799-1802.
45. Monson, R; Foulds, I; Foweraker, J; Welch, M; Salmond, GP. The Pseudomonas aeruginosa generalized transducing phage phiPA3 is a new member of the phiKZ-like group of 'jumbo' phages, and infects model laboratory strains and clinical isolates from cystic fibrosis patients. Microbiology, 2011 V. 157(Pt 3), P. 859-867. Epub 2010 Dec 16.
46. Krylov, VN; Akhverdian, VZ; Khrenova, EA; Cheremukhina, LV; Tiaglov, BV. Two types of molecular structure (composition) of a genome in one species of transposable bacteriophages of Pseudomonas aeruginosa. Genetika, 1986 V. 22(11), P. 2637-2648.
47. Akhverdian, VZ; Khrenova, EA; Lobanov, AO; Krylov, VN. Role of divergence in evolution of group B3 Pseudomonas aeruginosa transposable phage evolution. Russian Journal of Genetics, 1998 V. 34(6), P. 699-701.
48. Akhverdian, VZ; Lobanov, AO; Khrenova, EA; Krylov, VN. Recombinational origin of natural transposable phages of related species. Russian Journal of Genetics, 1998 V. 34(5), P. 697-700.
49. Krylov, VN; Ianenko, AS; Cheremukhina, LV. Differences in the allele state of genes controlling the specificity of adsorption in transposable phages of Pseudomonas aeruginosa. Genetika, 1986 V. 22(7), P. 1093-1098.
50. Roncero, C; Darzins, A; Casadaban, MJ. Pseudomonas aeruginosa transposable bacteriophages D3112 and B3 require pili and surface growth for adsorption. J. Bacteriol., 1990 V. 172(4), P. 1899-1904.
51. Krylov, VN; Bogush, VG; Ianenko, AS; Kirsanov, NB. Bacteriophages of Pseudomonas aeruginosa with DNA similar in structure to that of phage Mu1. II. Evidence of relatedness of bacteriophages D3112, B3 and B39: analysis of DNA digestion with restrictional endonucleases, isolation of recombinant of phages D3112 and B3. Genetika, 1980 V.16 (6), P. 975-984.
52. Holloway, BW; Römling, U; Tümmler, B. Genomic mapping of Pseudomonas aeruginosa PAO. Microbiology, 1994 V. 140 (Pt 11), P. 2907-2929.
53. Rehmat, S; Shapiro, JA. Insertion and replication of the Pseudomonas aeruginosa mutator phage D3112. Mol. Gen. Genet., 1983 V. 192(3), P. 416-423.
54. Gorbunova, SA; Ianenko, AS; Akhverdian, VZ; Reulets, MA; Krylov, VN. Expression of Pseudomonas aeruginosa transposable phages in Pseudomonas putida cells. I. The establishment of a lysogenic state and the effectiveness of lytic development. Genetika, 1985 V. 9, P. 1455-1463.
55. Plotnikova, TG; Kulakov, LA; Eremenko, EN; Fedorova, TV; Krylov, VN. Expression of the genome of Mu-like phage D3112 specific for Pseudomonas aeruginosa in Escherichia coli and Pseudomonas putida cells. Genetika, 1982 V. 7, P. 1075-1084.
56. Krylov, VN; Solov'eva, TI; Burkal'tseva, MV. Mucoid clones of Pseudomonas aeruginosa PAO1, surviving after induction of prophage transposons. Russian Journal of Genetics, 1995 V. 31 (10), P. 1170-1174.
57. Gerasimov, VA; Ianenko, AS; Akhverdian, VZ; Krylov, VN. Interaction between Pseudomonas aeruginosa phages-transposons: genetic analysis of the trait of inhibition by prophage D3112 of phage B39 development. Russian Journal of Genetics, 1996 V. 32(8), P. 1068-1073.
58. Gerasimov, VA; Ianenko, AS; Akhverdian, VZ; Krylov, VN. Phage-transposon interaction: the cip locus of prophage D3112 responsible for the inhibition of integration and transposition of related phage B39 of Pseudomonas aeruginosa. Genetika, 1985 V. 21(10), P. 1634-1642.
59. Miller, RV; Rubero, VJ. Mucoid conversion by phages of Pseudomonas aeruginosa strains from patients with cystic fibrosis. J. Clin. Microbiol., 1984 V. 19 (5), P. 717-719
60. Martin, DW; Schurr, MJ; Mudd, MH; Govan, JR; Holloway, BW; Deretic, V. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. USA, 1993 V. 90 (18), P. 8377-8381.
61. Jones, AM; Dodd, ME; Morris, J; Doherty, C; Govan, JR; Webb, AK. Clinical outcome for cystic fibrosis patients infected with transmissible Pseudomonas aeruginosa: an 8-year prospective study. Chest. 2010 V. 137 (6), P 1405 - nine. Epub 2010 Jan 15.
62. Williamson, SJ; McLaughlin, MR; Paul, JH. Interaction of the PhiHSIC virus with its host: lysogeny or pseudolysogeny? Appl. Environ. Microbiol., 2001 V. 4, P. 1682-1688.
63. Williamson, SJ; Paul, JH. Environmental factors that influence the transition from lysogenic to lytic existence in the phiHSIC/Listonella pelagia marine phage-host system. Microb. Ecol., 2006 V. 2, P. 217-225.
64. Ripp, S; Miller, RV. Dynamics of the pseudolysogenic response in slowly growing cells of Pseudomonas aeruginosa. Microbiology, 1998 V. 8, P. 2225-2232.
65. Lood, R; Collin, M. Characterization and genome sequencing of two Propionibacterium acnes phages displaying pseudolysogeny. BMC Genomics, 2011 V. 12, P. 198.
66. Khemayan, K; Pasharawipas, T; Puiprom, O; Sriurairatana, S; Suthienkul, O; Flegel, TW. Unstable lysogeny and pseudolysogeny in Vibrio harveyi siphovirus-like phage 1. Appl. Environ. Microbiol., 2006 V. 2, P. 1355-1363.
67. Sakaguchi, Y; Hayashi, T; Kurokawa, K; Nakayama, K; Oshima, K; Fujinaga, Y; Ohnishi, M; Ohtsubo, E; Hattori, M; Oguma, K. The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny. Proc. Natl. Acad. Sci. U S A, 2005 V. 48, P. 17472-17477.
68. Pleteneva, EA; Krylov, SV; Shaburova, OV; Burkal'tseva, MV; Miroshnikov, KA; Krylov, VN. Pseudolysogeny of Pseudomonas aeruginosa bacteria infected with phiKZ-like bacteriophages. Russian Journal of Genetics, 2010 V. 1, P. 20-25.
69. Krylov, SV; Pleteneva, EA; Bourkaltseva, MV; Shaburova, OV; Miroshnikov, KA; Lavigne, R; Cornelissen, A; Krylov, VN. Genome instability of Pseudomonas aeruginosa phages of the EL species: examination of virulent mutants. Russian Journal of Genetics, 2011 V. 2, P. 162-167.
70. Burkal'tseva, MV; Krylov, SV; Kropinski, AM; Pleteneva, EA; Shaburova, OV; Krylov, VN. Bacteriophage phi297, a New Species of Pseudomonas aeruginosa Temperate phages with a mosaic genome: potential use in phage therapy. Russian Journal of Genetics, 2011 V. 47, P. 794-798.
71. Krylov, VN; Zhazykov, IZh. Pseudomonas bacteriophage phiKZ - a possible model for studying the genetic control of morphogenesis. Genetika, 1978 V. 14(4), P. 678-685.
72. Krylov VN; Dela Cruz, DM; Hertveldt, K; Ackermann, HW. " phiKZ-like viruses" , a proposed new genus of myovirus bacteriophages. Arch. Virol., 2007 V. 152(10), P. 1955-1959. particles, plenty of similar gene products
73. Mesyanzhinov, VV; Robben, J; Grymonprez, B; Kostyuchenko, VA; Bourkaltseva, MV; Sykilinda, NN; Krylov, VN; Volckaert, G. The Genome of Bacteriophage phiKZ of Pseudomonas aeruginosa. J. Mol. Biol, 2002 V. 317, P. 1-19.
74. Hertveldt, K; Lavigne, R; Pleteneva, E; Sernova, N; Kurochkina, L; Korchevskii, R; Robben, J; Mesyanzhinov, V; Krylov, VN; Volckaert, G. Genome comparison of Pseudomonas aeruginosa large phages. J. Mol. Biol., 2005 V. 2, 354(3) P. 536-545. Epub 2005
75. Martin, DW; Holloway, BW; Deretic, V. Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor. J. Bacteriol., 1993 V. 175(4), P.
76. Jacoby, GA; Jacob, AE; Hedges, RW. Recombination between plasmids of incompatibility groups P-1 and P -2. J. Bacteriol., 1976 V. 127 (3), P. 1278-1285.
77. Jacoby, GA; Sutton, L. Properties of plasmids responsible for production of extended-spectrum beta -lactamases. Antimicrob Agents Chemother., 1991 V. 35(1), P. 164-169.
78. Philippon, AM; Paul, GC; Thabaut, AP; Jacoby, GA. Properties of a novel carbenicillin-hydrolyzing beta-lactamase (CARB-4) specified by an IncP-2 plasmid from Pseudomonas aeruginosa. Antimicrob Agents Chemother., 1986 V. 29(3), P. 519-520.
79. Freizon, EV; Kopylova, IuI; Cheremukhina, LV; Krylov, VN. The effect of the IncP-2-group plasmid on the growth of Pseudomonas aeruginosa bacteriophages. Genetika, 1989 V. 25(7), P. 1168-1178.
80. Krylov, VN; Eremenko, EN; Bogush, VG; Kirsanov, NB. Interaction of Pseudomonas aeruginosa plasmids and mu-like phages: the suppression of the early stages of cell infection by phage D3112 in the presence of plasmid RPL11. Genetika, 1982 V. 18(5), P. 743-752.
81. Gerasimov, VA; Eremenko, EN; Khrenova, EA; Gorbunova, SA; Krylov, VN. Stimulation of the lysogenization of Pseudomonas aeruginosa cells by phage transposon B39 induced by plasmid Rms163. Genetika, 1984 V. 20(7), P. 1080-1087.
82. Krylov, VN; Cheremukhina, LV; Gerasimov, VA; Ianenko, AS; Akhverdian, VZ. Two loci in the genome of the transposable phage B39 of Pseudomonas aeruginosa affecting the process of integration. I. Study of the properties of phages with the Pde- phenotype and mapping of the rms site. Genetika, 1986 V. 22(2), P. 209-218.
83. Plotnikova, TG; Akhverdian, VZ; Reulets, MA; Gorbunova, SA; Krylov, VN. Multiplicity of the integration sites of Mu-like bacteriophages into Pseudomonas aeruginosa chromosome and plasmids. Genetika, 1983 V. 19(10), P. 1604-1610.
84. Akhverdian, VZ; Kirsanov, NB; Khrenova, EA; Cheremukhina, LV; Rebentish, BA. Two loci in the genome of the Pseudomonas aeruginosa transposable phage B39 which affect the integration process. II. Mapping of the pdeX and pdeY loci by restriction and heteroduplex analysis. Genetika, 1986 V. 22(4), P. 566-575.
85. Krylov, SV; Kropinski, AM; Pleteneva, EA; Shaburova, OV; Bourlal'tseva MV; Miroshnikov, KA; Krylov, VN. Features of new D3-like phage phiPMG1 of Pseudomonas aeruginosa: genpme structure and prospects for use the phage in phage therapy. Russian Journal of Genetics, 2012 V. 48 (6) (in press)
86. Krylov, VN; Tolmachova, TO; Akhverdian, VZ. DNA homology in species of bacteriophages active on Pseudomonas aeruginosa. Arch. Virol., 1993 V. 1-2, P. 141-151.
87. Holloway, BW; Egan, JB; Monk, M. Lysogeny in Pseudomonas aeruginosa. Aust. J. Exp. Biol. Med. Sci., 1960 V. 38, P. 321-329.
88. Piekarowicz, A; Klyz, A; Majchrzak, M; Adamczyk-Poplawska, M; Maugel, TK; Stein, DC. Characterization of the dsDNA prophage sequences in the genome of Neisseria gonorrhoeae and visualization of productive bacteriophage. BMC Microbiol., 2007 V. 5 (7), P. 66.
89. John, CM; Griffiss, JM; Apicella, MA; Mandrell, RE; Gibson, BW. The structural basis for pyocin resistance in Neisseria gonorrhoeae lipooligosaccharides. J. Biol. Chem., 1991 V. 15;266(29), P. 19303-19311.
90. Kopylova, IuI; Gorbunova, SA; Krylov, VN. Interaction of heterologous bacteriophages: growth suppression of temperate PP56 phage of Pseudomonas putida by the transposable phage D3112 of Pseudomonas aeruginosa. Genetika, 1988 V. 5, P. 803-807.
91. Holloway, BW; Cooper, GN. Lysogenic conversion in Pseudomonas aeruginosa. J. Bacteriol., 1962 V. 84, P. 1321-1324.
92. Kuzio, J; Kropinski, AM. O-antigen conversion in Pseudomonas aeruginosa PAO1 by bacteriophage D3. J. Bacteriol. 1983 V. 155(1), P. 203-212.
93. Kropinski, AM. Sequence of the genome of the temperate, serotype-converting, Pseudomonas aeruginosa bacteriophage D3. J. Bacteriol., 2000 V. 182(21), P. 6066-6074.
94. Pleteneva, EA; Burkal'tseva, MV; Shaburova, OV; Krylov, SV; Pechnikova, EV; Sokolova, OS; Krylov, VN. TL, the new bacteriophage of Pseudomonas aeruginosa and its application for the search of halo-producing bacteriophages. Russian Journal of Genetics, 2011 V. 47(1), P. 5-9.
95. Pleteneva, EA; Shaburova, OV; Krylov, VN. A formal scheme of adsorpbtional receptors in Pseudomonas aeruginosa and possibilities for its practical implementation. Russian Journal of Genetics, 2009 V. 1, P. 35-40.
96. Cady, KC; White, AS; Hammond, JH; Abendroth, MD; Karthikeyan, RS; Lalitha, P; Zegans, ME; O'Toole, GA. Prevalence, conservation and functional analysis of Yersinia and Escherichia CRISPR regions in clinical Pseudomonas aeruginosa isolates. Microbiology. 2011 V. 157(Pt 2), P. 430-437. Epub 2010 Nov 16.
97. Zegans, ME; Wagner, JC; Cady, KC; Murphy, DM; Hammond, JH; O'Toole, GA. Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa. J. Bacteriol., 2009 V. 191(1), P. 210-219. Epub 2008 Oct 24.
98. Caruso, M; Shapiro, JA. Interactions of Tn7 and temperate phage F116L of Pseudomonas aeruginosa. Mol Gen Genet. 1982 V. 188(2), P. 292-298.
99. Li, Q; Shivachandra, SB; Leppla, SH; Rao, VB. Bacteriophage T4 capsid: a unique platform for efficient surface assembly of macromolecular complexes. J Mol Biol. 2006 V. 20;363(2), V. 577-588. Epub 2006 Aug 23.
100. Malys, N; Chang, DY; Baumann, RG; Xie, D; Black, LW. A bipartite bacteriophage T4 SOC and HOC randomized peptide display library:detection and analysis of phage T4 terminase (gp17) and late sigma factor (gp55) interaction. J. Mol. Biol. 2002 V. 31;319(2), P. 289-304.
101. Shaburova, OV; Hertveldt, K; de la Cruz, DMA; Krylov, SV; Pleteneva, EA; Bourkaltseva, MV; Lavigne, R; Volckaert, G; Krylov, VN. Comparison of New Giant Bacteriophages OBP and Lu11 of Soil Pseudomonads with Bacteriophages of the phiKZ-Supergroup of Pseudomonas aeruginosa. Russian Journal of Genetics, 2006 V. 42 (8), P. 877-885.